BioCentury
ARTICLE | Clinical News

AnervaX vaccine: Began Phase I dose escalation trial

May 9, 1994 7:00 AM UTC

Anergen Inc. (ANRG), Redwood City, Calif. Product: AnervaX vaccine, a synthetic peptide that elicits an antibody response against molecules of the major histocompatibility complex (MHC) that present s...